Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. lifted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 16.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 120,863 shares of the company’s stock after buying an additional 16,830 shares during the period. Bath & Body Works makes up approximately 0.8% of Lecap Asset Management Ltd.’s portfolio, making the stock its 16th largest position. Lecap Asset Management Ltd. owned about 0.05% of Bath & Body Works worth $3,858,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in BBWI. Envestnet Portfolio Solutions Inc. lifted its position in shares of Bath & Body Works by 5.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock worth $279,000 after purchasing an additional 277 shares in the last quarter. Empirical Finance LLC grew its stake in shares of Bath & Body Works by 3.6% during the first quarter. Empirical Finance LLC now owns 8,097 shares of the company’s stock worth $405,000 after purchasing an additional 278 shares in the last quarter. CWM LLC increased its holdings in Bath & Body Works by 6.6% in the second quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after buying an additional 314 shares during the last quarter. Northwest Bank & Trust Co lifted its holdings in Bath & Body Works by 2.5% during the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after buying an additional 315 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale boosted its position in shares of Bath & Body Works by 1.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after acquiring an additional 322 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Insider Activity at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.27% of the company’s stock.

Bath & Body Works Stock Performance

Shares of BBWI opened at $29.82 on Wednesday. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The stock has a market capitalization of $6.66 billion, a P/E ratio of 7.69, a P/E/G ratio of 0.94 and a beta of 1.77. The company’s fifty day moving average is $30.91 and its two-hundred day moving average is $38.34.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were issued a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a dividend yield of 2.68%. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on BBWI shares. Raymond James decreased their target price on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Wells Fargo & Company lowered their target price on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a research note on Monday, August 26th. Telsey Advisory Group restated an “outperform” rating and issued a $42.00 price objective on shares of Bath & Body Works in a research note on Thursday, September 26th. Finally, Piper Sandler reduced their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $42.35.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.